Valuation: EQL Pharma AB

Market Cap 607M 62.11M 54.63M 50.75M 46.67M 87.53M 6.01B 89.1M 237M 2.93B 233M 228M 10.18B P/E 2026
130x
P/E 2027 * 33.7x
Enterprise Value 923M 94.45M 83.07M 77.17M 70.98M 133M 9.15B 135M 360M 4.46B 355M 347M 15.48B EV / Sales 2026
4.55x
EV / Sales 2027 * 2x
Free-Float
38.91%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week-7.01%
Current month-13.29%
1 month-18.29%
3 months-59.78%
6 months-63.88%
Current year-64.45%
1 week 20.05
Extreme 20.05
21.6
1 month 20.05
Extreme 20.05
24.75
Current year 20.05
Extreme 20.05
67.5
1 year 20.05
Extreme 20.05
98.6
3 years 20.05
Extreme 20.05
98.6
5 years 20.05
Extreme 20.05
98.6
10 years 6.35
Extreme 6.35
98.6
Manager TitleAgeSince
Chief Executive Officer 40 2022-08-16
Director of Finance/CFO 51 2026-03-31
Chief Operating Officer 48 2022-08-16
Director TitleAgeSince
Chairman 61 2022-08-16
Director/Board Member 53 2019-12-31
Chairman 59 -
Date Insider Type Main position Quantity % Market Cap.
3/27/26 Sell

Chief Executive Officer

24,066 0.0815%
12/30/25 Buy

Executive/Senior Manager

1,000 0.0034%
12/23/25 Buy

Chief Operating Officer

19,225 0.0651%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-7.01%-77.47%-21.56% 62.11M
-2.40%-1.72%-24.42%-28.48% 15.25B
-3.50%-1.49%-31.89%-34.46% 7.07B
+0.18%-3.36%-23.07%-9.22% 5.86B
+1.10%+2.66%-8.18%-28.74% 3.94B
-0.16%+0.22%-30.68%-48.68% 3.16B
-0.37%-2.91%+9.36%-30.60% 3.14B
-3.98%-5.93%-42.91%-18.65% 2.93B
+1.50%+2.72%-16.23%+2.16% 2.57B
-0.83%-2.30%+90.53% - 2.5B
Average -0.93%-1.56%-15.50%-24.25% 4.65B
Weighted average by Cap. -1.47%-1.74%-16.76%-26.04%

Financials

2026 2027 *
Net sales 429M 43.91M 38.62M 35.88M 33M 61.88M 4.25B 62.99M 167M 2.07B 165M 161M 7.2B 495M 50.66M 44.56M 41.39M 38.07M 71.4M 4.91B 72.68M 193M 2.39B 190M 186M 8.3B
Net income 20M 2.05M 1.8M 1.67M 1.54M 2.88M 198M 2.94M 7.8M 96.69M 7.68M 7.52M 335M 18M 1.84M 1.62M 1.51M 1.38M 2.6M 178M 2.64M 7.02M 87.02M 6.92M 6.77M 302M
Net Debt 316M 32.34M 28.45M 26.43M 24.3M 45.58M 3.13B 46.4M 123M 1.53B 121M 119M 5.3B 381M 39M 34.3M 31.86M 29.3M 54.95M 3.78B 55.94M 149M 1.84B 146M 143M 6.39B
Logo EQL Pharma AB
EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.
Employees
60
Date Price Change Volume
26-07-23 SEK 20.55 -0.72% 18,528
26-07-22 SEK 20.70 -0.24% 76,913
26-07-21 SEK 20.75 +1.97% 34,494
26-07-20 SEK 20.35 -4.91% 51,677
26-07-17 SEK 21.40 -3.17% 34,766
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise